Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2619 | DSGN Design Therapeutics, Inc. - Common Stock | 11.49 USD | -1.71% | -8.95% | -22.42% | +61.15% | 719.06 M USD | ||
| 2633 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 12.70 USD | +0.87% | -10.06% | -8.50% | +12.39% | 701.60 M USD | ||
| 2656 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 7.82 USD | -1.51% | -6.79% | -23.33% | -4.52% | 684.23 M USD | ||
| 2657 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 3.47 USD | -1.98% | -10.80% | -27.10% | -51.54% | 683.76 M USD | ||
| 2667 | AURA Aura Biosciences, Inc. - Common Stock | 6.51 USD | +0.77% | +6.55% | -8.82% | +7.43% | 675.12 M USD | ||
| 2669 | MDXG MiMedx Group, Inc - Common Stock | 4.62 USD | +0.22% | -1.49% | -1.07% | -33.14% | 673.41 M USD | ||
| 2675 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.53 USD | -1.24% | -4.22% | -12.65% | -34.86% | 668.70 M USD | ||
| 2676 | IMMX Immix Biopharma, Inc. - Common Stock | 9.29 USD | -2.11% | -10.24% | -23.10% | +244.07% | 664.60 M USD | ||
| 2685 | NVCT Nuvectis Pharma, Inc. - Common Stock | 20.13 USD | -0.79% | -4.64% | -9.69% | +236.62% | 655.87 M USD | ||
| 2688 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.00 USD | -0.72% | +7.42% | -8.26% | +3.38% | 653.22 M USD | ||
| 2695 | PRME Prime Medicine, Inc. - Common Stock | 3.58 USD | -8.21% | +16.99% | +6.23% | -42.99% | 649.33 M USD | ||
| 2708 | IVA Inventiva S.A. - American Depository Shares | 3.32 USD | -1.48% | -7.00% | -24.72% | -31.55% | 641.55 M USD | ||
| 2723 | CLYM Climb Bio, Inc. - Common Stock | 10.86 USD | +1.40% | -1.63% | -26.62% | +98.54% | 623.76 M USD | ||
| 2763 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 7.13 USD | +4.70% | -0.97% | -15.12% | -39.58% | 576.82 M USD | ||
| 2768 | CRMD CorMedix Inc. - Common Stock | 7.32 USD | +0.55% | -0.68% | -9.85% | -35.22% | 570.55 M USD | ||
| 2773 | STTK Shattuck Labs, Inc. - Common Stock | 5.66 USD | 0.00% | -19.37% | -8.86% | +152.68% | 568.06 M USD | ||
| 2774 | DBVT DBV Technologies S.A. - American Depositary Shares | 9.55 USD | -2.25% | -12.55% | -29.31% | -38.43% | 565.48 M USD | ||
| 2778 | MNPR Monopar Therapeutics Inc. - Common Stock | 83.98 USD | +0.24% | +7.21% | -24.03% | +53.75% | 563.69 M USD | ||
| 2794 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 8.92 USD | +0.45% | -3.67% | -16.95% | +3.48% | 554.46 M USD | ||
| 2795 | HELP Cybin Inc. - Common Stock | 10.72 USD | +2.00% | -11.55% | -21.75% | +19.51% | 553.49 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表;ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日~15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |